Results 61 to 70 of about 72,792 (263)

Assessment of the need pacemaker implantation following aortic valve replacement with combined cardiac surgery

open access: yesРациональная фармакотерапия в кардиологии
Aim. To evaluate the risk factors for the development of cardiac conduction disorders and to determine their significance in temporary and permanent pacemaker implantation in patients after surgical aortic valve replacement and other combined cardiac ...
Yu. Y. Stolbikov   +4 more
doaj   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz   +15 more
wiley   +1 more source

Air Entrapment in a Pacemaker Pocket in a Child

open access: yesChildren
Background: Advances in pediatric electrophysiology have revolutionized cardiac care by offering patients treatments for increasingly complex cardiac rhythm and conduction disorders.
Vitaliy V. Suvorov, Dmitri O. Ivanov
doaj   +1 more source

Congenitally corrected transposition of the great arteries and implantation of a leadless pacemaker: a case report

open access: yesJournal of Cardiothoracic Surgery, 2023
Background Congenitally corrected transposition of the great arteries (ccTGA) is a rare cardiac anomaly and can lead to abnormal electrical activity of the heart.
Qiao-yuan Li   +5 more
doaj   +1 more source

Bioinspired Flexible and Stretchable Coil Structure from Ti3C2Tx MXene/AgNPs‐Functionalized Piezoelectric Nanofibers for Enhanced Energy Harvesting

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Ti3C2Tx MXene and Ag nanoparticles are embedded into piezoelectric nanofibers to form a stretchable, self‐powered coil that converts mechanical deformation into electrical energy. The device enables controllable power output during stretching and release while maintaining a compact and lightweight architecture, making it suitable for miniaturized ...
Fatemeh Mokhtari   +6 more
wiley   +1 more source

Modelling the pacemaker in event-B: towards methodology for reuse

open access: yes, 2012
The cardiac pacemaker is one of the system modelling problems posed to the Formal Methods community by the Grand Challenge for Dependable Systems Evolution.
Poppleton, Michael   +1 more
core  

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 809-818, April 2025.
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò   +20 more
wiley   +1 more source

Pacemaker site infection caused by Rapidly Growing Nontuberculous Mycobacteria (RGM)

open access: yesBiomedical and Biotechnology Research Journal, 2018
There has been an increased use of cardiac pacemaker device utilization in cardiac patients with a corresponding increase of device-related infections in these patients.
Jhansi Vani Devana   +2 more
doaj   +1 more source

Vascular turbine powering a cardiac pacemaker: an in-vivo case study [PDF]

open access: yes, 2014
Background: Today’s medical devices are powered by batteries with a limited energy storage capacity. Depleted batteries have to be replaced, exposing the patients to the risk of adverse events.
Jonsson, Magnus   +4 more
core  

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy